Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 10 |
GO:0042995 | cell projection | 2 | 10 |
GO:0043226 | organelle | 2 | 10 |
GO:0043227 | membrane-bounded organelle | 3 | 10 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 10 |
Related structures:
AlphaFold database: A4HNT1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 167 | 171 | PF00656 | 0.496 |
CLV_NRD_NRD_1 | 132 | 134 | PF00675 | 0.292 |
CLV_NRD_NRD_1 | 73 | 75 | PF00675 | 0.231 |
CLV_PCSK_FUR_1 | 162 | 166 | PF00082 | 0.489 |
CLV_PCSK_KEX2_1 | 138 | 140 | PF00082 | 0.304 |
CLV_PCSK_KEX2_1 | 164 | 166 | PF00082 | 0.611 |
CLV_PCSK_PC1ET2_1 | 138 | 140 | PF00082 | 0.296 |
CLV_PCSK_PC1ET2_1 | 164 | 166 | PF00082 | 0.529 |
CLV_PCSK_SKI1_1 | 10 | 14 | PF00082 | 0.433 |
CLV_PCSK_SKI1_1 | 138 | 142 | PF00082 | 0.269 |
CLV_PCSK_SKI1_1 | 204 | 208 | PF00082 | 0.605 |
CLV_PCSK_SKI1_1 | 215 | 219 | PF00082 | 0.369 |
DEG_APCC_DBOX_1 | 214 | 222 | PF00400 | 0.507 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.366 |
DOC_CDC14_PxL_1 | 87 | 95 | PF14671 | 0.430 |
DOC_MAPK_gen_1 | 119 | 128 | PF00069 | 0.355 |
DOC_MAPK_gen_1 | 42 | 51 | PF00069 | 0.496 |
DOC_MAPK_MEF2A_6 | 88 | 95 | PF00069 | 0.480 |
DOC_PP1_RVXF_1 | 202 | 209 | PF00149 | 0.611 |
DOC_USP7_MATH_1 | 166 | 170 | PF00917 | 0.709 |
DOC_USP7_MATH_1 | 180 | 184 | PF00917 | 0.597 |
DOC_USP7_MATH_1 | 50 | 54 | PF00917 | 0.368 |
DOC_USP7_UBL2_3 | 134 | 138 | PF12436 | 0.496 |
DOC_USP7_UBL2_3 | 15 | 19 | PF12436 | 0.445 |
DOC_USP7_UBL2_3 | 246 | 250 | PF12436 | 0.556 |
DOC_WW_Pin1_4 | 151 | 156 | PF00397 | 0.630 |
DOC_WW_Pin1_4 | 157 | 162 | PF00397 | 0.659 |
DOC_WW_Pin1_4 | 178 | 183 | PF00397 | 0.697 |
LIG_14-3-3_CanoR_1 | 139 | 145 | PF00244 | 0.513 |
LIG_14-3-3_CanoR_1 | 74 | 79 | PF00244 | 0.424 |
LIG_BIR_III_2 | 179 | 183 | PF00653 | 0.483 |
LIG_FHA_1 | 90 | 96 | PF00498 | 0.440 |
LIG_FHA_2 | 127 | 133 | PF00498 | 0.455 |
LIG_FHA_2 | 193 | 199 | PF00498 | 0.698 |
LIG_FHA_2 | 75 | 81 | PF00498 | 0.419 |
LIG_LIR_Nem_3 | 111 | 115 | PF02991 | 0.387 |
LIG_SH2_CRK | 115 | 119 | PF00017 | 0.430 |
LIG_SH2_STAT5 | 115 | 118 | PF00017 | 0.411 |
LIG_SH2_STAT5 | 72 | 75 | PF00017 | 0.413 |
LIG_SUMO_SIM_anti_2 | 220 | 227 | PF11976 | 0.483 |
LIG_SUMO_SIM_anti_2 | 231 | 237 | PF11976 | 0.420 |
LIG_SUMO_SIM_anti_2 | 35 | 41 | PF11976 | 0.430 |
LIG_SUMO_SIM_anti_2 | 92 | 97 | PF11976 | 0.467 |
LIG_SUMO_SIM_par_1 | 217 | 223 | PF11976 | 0.457 |
LIG_SUMO_SIM_par_1 | 47 | 53 | PF11976 | 0.409 |
LIG_TRAF2_1 | 129 | 132 | PF00917 | 0.393 |
LIG_TRAF2_1 | 195 | 198 | PF00917 | 0.591 |
LIG_UBA3_1 | 67 | 75 | PF00899 | 0.467 |
MOD_CDK_SPK_2 | 157 | 162 | PF00069 | 0.627 |
MOD_CDK_SPxxK_3 | 157 | 164 | PF00069 | 0.631 |
MOD_CK1_1 | 151 | 157 | PF00069 | 0.614 |
MOD_CK1_1 | 175 | 181 | PF00069 | 0.620 |
MOD_CK1_1 | 183 | 189 | PF00069 | 0.578 |
MOD_CK1_1 | 220 | 226 | PF00069 | 0.379 |
MOD_CK2_1 | 126 | 132 | PF00069 | 0.413 |
MOD_CK2_1 | 192 | 198 | PF00069 | 0.614 |
MOD_GlcNHglycan | 166 | 169 | PF01048 | 0.630 |
MOD_GlcNHglycan | 185 | 188 | PF01048 | 0.557 |
MOD_GlcNHglycan | 201 | 204 | PF01048 | 0.527 |
MOD_GlcNHglycan | 211 | 214 | PF01048 | 0.473 |
MOD_GlcNHglycan | 83 | 87 | PF01048 | 0.222 |
MOD_GSK3_1 | 13 | 20 | PF00069 | 0.436 |
MOD_GSK3_1 | 164 | 171 | PF00069 | 0.619 |
MOD_GSK3_1 | 174 | 181 | PF00069 | 0.607 |
MOD_GSK3_1 | 183 | 190 | PF00069 | 0.580 |
MOD_GSK3_1 | 252 | 259 | PF00069 | 0.462 |
MOD_GSK3_1 | 50 | 57 | PF00069 | 0.363 |
MOD_N-GLC_1 | 54 | 59 | PF02516 | 0.296 |
MOD_NEK2_1 | 13 | 18 | PF00069 | 0.359 |
MOD_NEK2_1 | 149 | 154 | PF00069 | 0.529 |
MOD_NEK2_1 | 207 | 212 | PF00069 | 0.509 |
MOD_NEK2_1 | 217 | 222 | PF00069 | 0.456 |
MOD_PIKK_1 | 252 | 258 | PF00454 | 0.381 |
MOD_PKA_1 | 138 | 144 | PF00069 | 0.463 |
MOD_PKA_1 | 164 | 170 | PF00069 | 0.693 |
MOD_PKA_1 | 74 | 80 | PF00069 | 0.355 |
MOD_PKA_2 | 138 | 144 | PF00069 | 0.496 |
MOD_PKA_2 | 164 | 170 | PF00069 | 0.573 |
MOD_Plk_1 | 226 | 232 | PF00069 | 0.431 |
MOD_Plk_1 | 35 | 41 | PF00069 | 0.413 |
MOD_Plk_1 | 54 | 60 | PF00069 | 0.496 |
MOD_Plk_1 | 82 | 88 | PF00069 | 0.496 |
MOD_Plk_4 | 217 | 223 | PF00069 | 0.401 |
MOD_Plk_4 | 63 | 69 | PF00069 | 0.355 |
MOD_Plk_4 | 91 | 97 | PF00069 | 0.462 |
MOD_ProDKin_1 | 151 | 157 | PF00069 | 0.638 |
MOD_ProDKin_1 | 178 | 184 | PF00069 | 0.696 |
MOD_SUMO_rev_2 | 127 | 136 | PF00179 | 0.481 |
TRG_DiLeu_BaEn_1 | 231 | 236 | PF01217 | 0.515 |
TRG_ENDOCYTIC_2 | 109 | 112 | PF00928 | 0.437 |
TRG_ER_diArg_1 | 118 | 121 | PF00400 | 0.355 |
TRG_Pf-PMV_PEXEL_1 | 5 | 9 | PF00026 | 0.378 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P7V8 | Leptomonas seymouri | 62% | 100% |
A0A0S4JS78 | Bodo saltans | 43% | 100% |
A0A3S7XAD6 | Leishmania donovani | 83% | 100% |
A4ICR3 | Leishmania infantum | 83% | 100% |
D0A2P1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 95% |
E9ASJ1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 80% | 100% |
O43822 | Homo sapiens | 35% | 100% |
Q4Q205 | Leishmania major | 80% | 100% |
Q8C6G1 | Mus musculus | 36% | 100% |
V5DRP5 | Trypanosoma cruzi | 43% | 94% |